These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 23147412

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.
    Hirai H, Sootome H, Nakatsuru Y, Miyama K, Taguchi S, Tsujioka K, Ueno Y, Hatch H, Majumder PK, Pan BS, Kotani H.
    Mol Cancer Ther; 2010 Jul; 9(7):1956-67. PubMed ID: 20571069
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors.
    Pitt SC, Chen H, Kunnimalaiyaan M.
    Ann Surg Oncol; 2009 Oct; 16(10):2936-42. PubMed ID: 19588205
    [Abstract] [Full Text] [Related]

  • 6. MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
    Chen JY, Cook MR, Pinchot SN, Kunnimalaiyaan M, Chen H.
    J Surg Res; 2010 Jan; 158(1):15-9. PubMed ID: 19765735
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.
    Pant A, Lee II, Lu Z, Rueda BR, Schink J, Kim JJ.
    PLoS One; 2012 Jan; 7(7):e41593. PubMed ID: 22911820
    [Abstract] [Full Text] [Related]

  • 10. Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
    Pitt SC, Chen H, Kunnimalaiyaan M.
    J Am Coll Surg; 2009 Jul; 209(1):82-8. PubMed ID: 19651067
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells.
    Zitzmann K, Ailer G, Vlotides G, Spoettl G, Maurer J, Göke B, Beuschlein F, Auernhammer CJ.
    Int J Oncol; 2013 Dec; 43(6):1824-32. PubMed ID: 24100469
    [Abstract] [Full Text] [Related]

  • 15. AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors.
    Gloesenkamp CR, Nitzsche B, Ocker M, Di Fazio P, Quint K, Hoffmann B, Scherübl H, Höpfner M.
    Int J Oncol; 2012 Mar; 40(3):876-88. PubMed ID: 22075556
    [Abstract] [Full Text] [Related]

  • 16. Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines.
    Larsson DE, Hassan S, Larsson R, Oberg K, Granberg D.
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):5-12. PubMed ID: 19381631
    [Abstract] [Full Text] [Related]

  • 17. Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma.
    Knowles JA, Golden B, Yan L, Carroll WR, Helman EE, Rosenthal EL.
    Laryngoscope; 2011 Nov; 121(11):2359-65. PubMed ID: 22020886
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors.
    Kidd M, Schally AV, Pfragner R, Malfertheiner MV, Modlin IM.
    Cancer; 2008 Mar 15; 112(6):1404-14. PubMed ID: 18224665
    [Abstract] [Full Text] [Related]

  • 19. Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms.
    Zitzmann K, Vlotides G, Brand S, Lahm H, Spöttl G, Göke B, Auernhammer CJ.
    Endocr Relat Cancer; 2012 Jun 15; 19(3):423-34. PubMed ID: 22499437
    [Abstract] [Full Text] [Related]

  • 20. The molecular pathogenesis and management of bronchial carcinoids.
    Cakir M, Grossman A.
    Expert Opin Ther Targets; 2011 Apr 15; 15(4):457-91. PubMed ID: 21275849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.